Latest News

STAT Plus: What’s a polygenic risk score and how good is it at predicting disease?

The commercial landscape for genetic testing has come a long way from testing only for certain inherited genes directly linked to disease, such as BRCA genes whose mutations heighten risk for breast cancer. Myriad Genetics made its name with BRCA testing, but in 2017 the company also began marketing a different type of test, one that turns up multiple genetic variants found throughout a woman’s genome that together may point toward her risk of breast cancer. Earlier this year Ambry Genetics began marketing a similar test to estimate a man’s risk of prostate cancer.

These tests generate polygenic risk scores, gathering multiple genetic variants that together are used to predict someone’s chance of developing a disease. But what are these scores, and how much faith should people put in them?

Continue to STAT Plus to read the full story…

Source link

Related posts

Medical News Today: Melanoma: Keeping these molecules apart could stop cancer spread


Tocilizumab more effective than Rituximab in RA patients with low B-cell levels


Sales of “KIRIN iMUSE YOGURT & LEMON FLAVORED DRINK”, Which Began in Vietnam in September, Are Doing Very Well


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy